PharmaBharatPharma & Life Sciences Jobs
Menu

Clinical Trials Live

Discover clinical trials around the world.

Explore public ClinicalTrials.gov records by country, condition, phase and recruitment status. Find a study, review its eligibility criteria, and connect with the listed research team.

recruiting worldwide
64,821
recruiting or opening soon worldwide
94,766
recruiting with a site in India
608

Registry counts refresh hourly when this page is visited.

More search options

Study status can differ from individual site status. Check the study details.

Reset filters

Applied filtersPhase 3

12 of 4,153 studies worldwide

Public records · ClinicalTrials.gov · recently updated first

Phase 3RecruitingStart: 16 Jun 2020

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8

Anchorage, United States; Fairbanks, United States; Gilbert, United States +694 more

SponsorNational Cancer Institute (NCI)
1151reported sites
Phase 3RecruitingStart: 27 Mar 2025

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma · Metastatic Oral Cavity Squamous Cell Carcinoma · Metastatic Oropharyngeal Squamous Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma · Recurrent Hypopharyngeal Squamous Cell Carcinoma · Recurrent Laryngeal Squamous Cell Carcinoma · Recurrent Neck Squamous Cell Carcinoma of Unknown Primary · Recurrent Oral Cavity Squamous Cell Carcinoma · Recurrent Oropharyngeal Squamous Cell Carcinoma · Refractory Head and Neck Squamous Cell Carcinoma · Refractory Hypopharyngeal Squamous Cell Carcinoma · Refractory Laryngeal Squamous Cell Carcinoma · Refractory Oral Cavity Squamous Cell Carcinoma · Refractory Oropharyngeal Squamous Cell Carcinoma · Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Stage IV Hypopharyngeal Carcinoma AJCC v8 · Stage IV Laryngeal Cancer AJCC v8 · Stage IV Lip and Oral Cavity Cancer AJCC v8 · Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Little Rock, United States; Marysville, United States; Palo Alto, United States +159 more

SponsorNational Cancer Institute (NCI)
200reported sites
Phase 3RecruitingStart: 27 Nov 2023

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Negative Breast Carcinoma · Hormone Receptor-Positive Breast Carcinoma

Birmingham, United States; Anchorage, United States; Tucson, United States +415 more

SponsorNational Cancer Institute (NCI)
561reported sites

Source: ClinicalTrials.gov · Data fetched 20 Oct 2026, 14:30 GMT+0530

Registry data timestamp: 2026-10-19T09:00:04

Registry content is reformatted for readability; original study text is not rewritten. Missing information is labelled “Not reported”. Records are supplied by study sponsors or investigators and can change.

ClinicalTrials.gov does not endorse PharmaBharat. Listing a study does not mean it has been evaluated or approved by a government agency. Information is for research awareness and is not medical advice. Data source terms · Registry disclaimer

This catalogue includes records registered on ClinicalTrials.gov, including studies outside India. It does not include every study in every national registry. PharmaBharat does not run studies, assess eligibility or enrol participants.